Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 6:08 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 58 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Intravenous Access Clear all

Conditions: Catheterization, Peripheral, Phlebotomy
Interventions: VeinViewer; Device
Lead sponsor: Children's Hospital and Health System Foundation, Wisconsin; Other
Eligibility: Up to 19 Years
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Difficult IV Access
Interventions: peripheral IV access procedure, Peripheral IJ access procedure; Procedure
Lead sponsor: HealthPartners Institute; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: Veins
Interventions: Not listed
Lead sponsor: Christie Medical Holdings, Inc.; Industry
Eligibility: Not listed
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Intravenous Access
Interventions: Single Use Vein Entry Indicator Device; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: Up to 18 Years
Enrollment: 169 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Difficult Intravenous Access, Midline Catheter, Peripheral Intravenous Catheter, Emergency Department Patient
Interventions: 10-cm Single Lumen Mildine, 4.78 cm Long Peripheral Intravenous Catheter; Device
Lead sponsor: Albany Medical College; Other
Eligibility: 18 Years and older
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Albany, New York

Conditions: Hypoplasminogenemia
Interventions: Ryplazim; Biological
Lead sponsor: Prometic Biotherapeutics, Inc.; Industry
Eligibility: Not listed
U.S. locations: 3
States / cities: Beverly Hills, California • Indianapolis, Indiana • Nashville, Tennessee

Conditions: Difficult Peripheral IV Access
Interventions: IO access using EZ-IO®; Procedure
Lead sponsor: WellSpan Health; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania • York, Pennsylvania

Conditions: Disaster Medicine, Difficult Intravenous Access, Dehydration
Interventions: Human recombinant hyaluronidase (HRH), Enzymatically Augmented Subcutaneous Infusion (EASI) line placement; Drug · Procedure
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Intravenous Access
Interventions: IV SafeLock; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Difficult Intravenous Access in Pediatrics
Interventions: Ultrasound guidance, Traditional intravenous access; Procedure
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: Up to 18 Years
Enrollment: 163 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Vascular Access Complication
Interventions: AccuCath IV Catheter Device, Conventional IV Catheter Device; Device
Lead sponsor: C. R. Bard; Industry
Eligibility: 18 Years to 89 Years
Enrollment: 248 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Acute Ischemic Stroke, Mesenchymal Stem Cells, Stroke, Acute, Stroke/Brain Attack, Stroke, Ischemic
Interventions: Allogeneic human mesenchymal stem cells (Allo-hMSCs); Drug
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 80 Years
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Tourniquet
Interventions: disposable elastic tourniquet, blood pressure cuff; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 121 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Need for IV Access
Interventions: Long axis IV placement with ultrasound, Short axis IV placement with ultrasound; Device
Lead sponsor: Beth Israel Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Pediatric Disorder
Interventions: Accuvein AV400; Device
Lead sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; Other
Eligibility: Up to 24 Months
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Torrance, California

Conditions: Peripheral Intravenous Vein Catheter Phlebitis, Intravenous Infection
Interventions: B. Braun 6.35cm 20 gauge ultralong intravenous catheter, BD 5.71 cm 20 gauge Accucath; Device
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years and older
Enrollment: 360 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Catheterization, Peripheral
Interventions: Ultrasound guidance, Non-ultrasound guidance; Device · Procedure
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: Up to 17 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Pain on IV Injection of Propofol.
Interventions: Lidocaine/tetracaine transdermal patch, Saline, Lidocaine; Device · Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 6 Years to 17 Years
Enrollment: 76 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Crohn's Disease, Ulcerative Colitis
Interventions: Vedolizumab IV; Drug
Lead sponsor: Takeda; Industry
Eligibility: 2 Years and older
U.S. locations: 3
States / cities: San Francisco, California • Atlanta, Georgia • Seattle, Washington

Conditions: Vascular Access Devices
Interventions: Standard IV dressing, Standard IV dressing plus a tissue adhesive peripheral IV securement device; Device
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years and older
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Colorectal Cancer
Interventions: Telisotuzumab adizutecan, Bevacizumab, Trifluridine/Tipiracil; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years and older
Enrollment: 990 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 18
States / cities: Goodyear, Arizona • Springdale, Arkansas • Duarte, California + 15 more

Conditions: Difficult-to-access Veins for Intravenous Cannulation
Interventions: Veinplicity with tourniquet, Tourniquet; Device
Lead sponsor: Physeon GmbH; Industry
Eligibility: 22 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 3
States / cities: Plymouth, Minnesota • Rochester, Minnesota • Saint Paul, Minnesota

Conditions: Patients With Peripheral Intravenous Access Lines
Interventions: Ultrasound-guided peripheral intravenous access line placement, Landmark Approach to peripheral intravenous access line placement; Procedure
Lead sponsor: George Washington University; Other
Eligibility: 18 Years and older
Enrollment: 1,189 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Airway Control
Interventions: Not listed
Lead sponsor: Vidacare Corporation; Industry
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Omaha, Nebraska

Search by objective public record fields.

VeinViewer for Peripheral IV Placement in Children With Difficult Intravenous (IV) Access

Peripheral Internal Jugular Vein ('Peripheral IJ') Access in Patients Identified as Difficult Intravenous Access

Percentage Venous Options in Pediatrics & Adults

A Study to Evaluate SU-VEID™ for Improving Peripheral Venous Access Success in Children

Single Lumen Midline Catheter vs Long Peripheral Intravenous Cather for Difficult Intravenous Access in the ED

A Treatment Protocol for Expanded Access Administration of Prometic Plasminogen Due to Closure of Clinical Trial

Intraosseous Access in the Emergency Department for Patients With Failed Attempts at Intravenous Access: A Randomized Trial Examining Resource Utilization and Patient Satisfaction

EASI Access II --- Follow-up Study to the EASI Access Trial

IV SafeLock Device Functionality in Emergency Department

Ultrasound Guided IV Access in a Pediatric Emergency Department

AccuCath Guidewire Intravenous (IV) Device Versus Conventional IV Catheter In General Nursing Use

Expanded Access Multi-Patient Experimental Treatment Involving Allogeneic Human Mesenchymal Stem Cells (hMSCs) in Subjects With Acute Ischemic Stroke (EXPAND)

The Effect of Two Different Tourniquet Techniques on Peripheral IV Access Success Rates

Ultrasound Guided Peripheral Intravenous Catheter Insertion in the Hospitalized Patient: Long vs. Short Axis Placement

A Comparison of Accuvein to Standard IV Access in Children 0 to 24 Months of Age in the Pediatric ED

Evaluating the Role of the Guidewire in Peripheral Intravenous Access: A Randomized Controlled Trial of Ultrasound-Guided Catheter Survival

Use of Ultrasound Guidance to Facilitate Obtaining Peripheral Intravenous Access

Combining Placing a Synera Patch With Propofol/Lidocaine Mixture to Decrease Pain With IV Propofol Injection

Expanded Access to Vedolizumab for Children and Teenagers With Ulcerative Colitis or Crohn's Disease in the USA

Peripheral Intravenous Catheter Securement With Tissue Adhesive

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

Veinplicity for Improved Venous Access: The VIVA Trial

Evaluate Initial Success Rate of Ultrasound Guided Versus Landmark Approach For Peripheral Intravenous Access

Rapid Sequence Intubation Drug Delivery Using Intraosseous and IV Access in Pediatric Patients Observational Study